However, compared with the C group, CRS and A2AR agonist significantly suppressed increases in body weight in the M group (from the 7th day, p < 0.01) and CC group (from the 14th day, p < 0.01), respectively. This evidence concerns the gene ADORA2A and congenital rubella syndrome.